Response

Affiliations

¹ Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Electronic address: ltarantomontemurro@bwh.harvard.edu.
² Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Adelaide Institute for Sleep Health (AISH), Flinders Health and Medical Research Institute (FHMRI), Flinders University, Adelaide, South Australia, Australia.
³ Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

Comment

Luigi Taranto-Montemurro et al. Chest. 2021 May.

. 2021 May;159(5):2118-2119.

doi: 10.1016/j.chest.2020.12.042.

¹ Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Electronic address: ltarantomontemurro@bwh.harvard.edu.
² Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Adelaide Institute for Sleep Health (AISH), Flinders Health and Medical Research Institute (FHMRI), Flinders University, Adelaide, South Australia, Australia.
³ Division of Sleep and Circadian Disorders, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

No abstract available

Comment on

Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L, Messineo L, Azarbarzin A, Vena D, Hess LB, Calianese NA, White DP, Wellman A, Sands SA. Taranto-Montemurro L, et al. Chest. 2020 Jun;157(6):1626-1636. doi: 10.1016/j.chest.2020.01.012. Epub 2020 Jan 30. Chest. 2020. PMID: 32006590 Free PMC article. Clinical Trial.
Could Atomoxetine-Oxybutynin, a Combination of Medications Being Explored for OSA Management, Have Any Effect on Sleep Bruxism or Jaw Muscle Tone?
Lavigne G, Herrero Babiloni A, Fabbro CD, Mayer P. Lavigne G, et al. Chest. 2021 May;159(5):2117-2118. doi: 10.1016/j.chest.2020.11.072. Chest. 2021. PMID: 33965144 No abstract available.